本页面由Tiger Trade Technology Pte. Ltd.提供服务

Prime Medicine, Inc.

3.67
-0.1200-3.17%
盘后3.65-0.0202-0.55%19:58 EDT
成交量:151.94万
成交额:558.35万
市值:6.62亿
市盈率:-2.71
高:3.79
开:3.79
低:3.61
收:3.79
52周最高:6.94
52周最低:1.11
股本:1.81亿
流通股本:9,979.87万
量比:0.80
换手率:1.52%
股息:- -
股息率:- -
每股收益(TTM):-1.3521
每股收益(LYR):-1.3521
净资产收益率:-146.81%
总资产收益率:-40.68%
市净率:5.48
市盈率(LYR):-2.71

数据加载中...

公司资料

公司名字:
Prime Medicine, Inc.
交易所:
NASDAQ
成立时间:
2019
员工人数:
146
公司地址:
60 First Street,Cambridge,Massachusetts,United States
邮编:
02141
电话:
传真:
- -
简介:
Prime Medicine, Inc.于2019年9月在特拉华州注册成立。该公司是一家生物技术公司,致力于提供一类新的差异化一次性治疗基因疗法— Prime Editors,通过部署Prime Editing技术来解决最广泛的疾病谱。

董事

名称
职位
Allan Reine
Chief Financial Officer,Chief Executive Officer and Director
Jeffrey Marrazzo
Director and Executive Chair
David Schenkein
Director
Kaye Foster
Director
Michael Kelly
Director
Robert Taylor NELSEN
Director
Thomas Cahill
Director
Wendy Chung
Director

股东

名称
职位
Allan Reine
Chief Financial Officer,Chief Executive Officer and Director
Ann Lee
Chief Technical Officer
Carman Alenson
Chief Accounting Officer
Jeffrey Marrazzo
Director and Executive Chair